Eli Lilly, Regeneron in FDA PreCheck manufacturing program
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for…
Cramer: The data center is suddenly suspect. Can Big Tech fix it?
I sure didn’t want what happened to occur, at least not during my vacation, of all things. But it…
Medicare will soon cover obesity drugs, but many seniors may not know
Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news…
The AI trade cooled and oil sank. A closer look at Wall Street’s volatile week
Wall Street spent the week debating who the biggest winners and losers of the artificial intelligence boom will…
Healthcare stocks have caught fire, sending all 3 of our names to record highs
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
GLP-1 weight loss pills may be bad thing for job insurance coverage
The new GLP-1 pills are likely to boost consumer demand for these popular weight-loss drugs. But it could…
We’re trimming a stock into strength, raising our price target
We are selling 50 shares of Cardinal Health at roughly $235. Following the trade, Jim Cramer’s Charitable Trust…
Space race comes for pharma: Why drug development is heading to orbit
The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch…
Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as…
Weight loss drug maker stock sinks 25% as safety data spooks investors
Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data…
Jim Cramer says look to buy these 5 stocks outside the AI trade for diversification
CNBC’s Jim Cramer on Tuesday provided investors a handful of beaten-down stocks that he believes could outperform if…
CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…